Association between type of drinking water and upper gastrointestinal cancer incidence in the Linxian General Population

BMC Cancer. 2023 May 4;23(1):397. doi: 10.1186/s12885-023-10887-2.

Abstract

Background: This study aimed to explore the association between drinking water source and risk of upper gastrointestinal (UGI) cancer, including esophageal cancer (EC) and gastric cancer (GC), in the Linxian General Population Nutrition Intervention Trial (NIT) cohort.

Methods: In this study, we used data from the Linxian NIT cohort, which included 29,584 healthy adults aged 40 to 69 years. Subjects were enrolled in April 1986 and followed up until March 2016. Tap water drinking status and demographic characteristics were collected at baseline. Subjects who drank tap water were treated as the exposed group. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) were estimated using the Cox proportional hazard model.

Results: A total of 5,463 cases of UGI cancer were identified during the 30-year follow-up period. After adjusting for multiple factors, the incidence rate of UGI cancer in participants who drank tap water was significantly lower compared with individuals in the control (HR = 0.91, 95% CI: 0.86-0.97). A similar association was observed between tap water drinking and EC incidence (HR = 0.89, 95% CI: 0.82-0.97). The association between drinking tap water and risk of UGI cancer and EC incidence did not vary across the subgroup by age and gender (All Pinteraction > 0.05). For EC incidence, an interaction effect was observed for riboflavin/niacin supplements and drinking water source (Pinteraction = 0.03). No association was observed between drinking water source and GC incidence.

Conclusions: In this prospective cohort study in Linxian, participants who drank tap water had a lower risk of EC incidence. As a source of drinking water, use of tap water may reduce the risk of EC by avoiding exposure to nitrate/nitrite. Measures should be taken to improve the quality of drinking water in high-incidence areas of EC.

Trial registration: The trial is registered with ClinicalTrials.gov (NCT00342654, 21/06/2006), and the trial name is Nutrition Intervention Trials in Linxian Follow-up Study.

Keywords: China; Cohort Study; Drinking water; Esophageal Neoplasms; Stomach Neoplasms.

MeSH terms

  • Adult
  • China / epidemiology
  • Drinking Water* / adverse effects
  • Esophageal Neoplasms* / epidemiology
  • Follow-Up Studies
  • Humans
  • Incidence
  • Prospective Studies
  • Risk Factors
  • Stomach Neoplasms* / epidemiology
  • Stomach Neoplasms* / etiology

Substances

  • Drinking Water

Associated data

  • ClinicalTrials.gov/NCT00342654